210 related articles for article (PubMed ID: 34038767)
1. Genetic deficiency or pharmacological inhibition of soluble epoxide hydrolase ameliorates high fat diet-induced pancreatic β-cell dysfunction and loss.
Koike S; Hsu MF; Bettaieb A; Chu B; Matsumoto N; Morisseau C; Havel PJ; Huising MO; Hammock BD; Haj FG
Free Radic Biol Med; 2021 Aug; 172():48-57. PubMed ID: 34038767
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.
Bettaieb A; Nagata N; AbouBechara D; Chahed S; Morisseau C; Hammock BD; Haj FG
J Biol Chem; 2013 May; 288(20):14189-14199. PubMed ID: 23576437
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance.
Luria A; Bettaieb A; Xi Y; Shieh GJ; Liu HC; Inoue H; Tsai HJ; Imig JD; Haj FG; Hammock BD
Proc Natl Acad Sci U S A; 2011 May; 108(22):9038-43. PubMed ID: 21571638
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.
Bettaieb A; Koike S; Hsu MF; Ito Y; Chahed S; Bachaalany S; Gruzdev A; Calvo-Rubio M; Lee KSS; Inceoglu B; Imig JD; Villalba JM; Zeldin DC; Hammock BD; Haj FG
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2758-2765. PubMed ID: 28757338
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model.
Chen L; Fan C; Zhang Y; Bakri M; Dong H; Morisseau C; Maddipati KR; Luo P; Wang CY; Hammock BD; Wang MH
Prostaglandins Other Lipid Mediat; 2013; 104-105():42-8. PubMed ID: 23247129
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy.
Jiang XS; Xiang XY; Chen XM; He JL; Liu T; Gan H; Du XG
Cell Death Dis; 2020 May; 11(5):385. PubMed ID: 32439839
[TBL] [Abstract][Full Text] [Related]
7. Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis.
Luo P; Chang HH; Zhou Y; Zhang S; Hwang SH; Morisseau C; Wang CY; Inscho EW; Hammock BD; Wang MH
J Pharmacol Exp Ther; 2010 Aug; 334(2):430-8. PubMed ID: 20439437
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
[TBL] [Abstract][Full Text] [Related]
9. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Soluble Epoxide Hydrolase 2 Ameliorates Diabetic Keratopathy and Impaired Wound Healing in Mouse Corneas.
Sun H; Lee P; Yan C; Gao N; Wang J; Fan X; Yu FS
Diabetes; 2018 Jun; 67(6):1162-1172. PubMed ID: 29615440
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney.
Luo J; Hu S; Fu M; Luo L; Li Y; Li W; Cai Y; Dong R; Yang Y; Tu L; Xu X
J Biol Chem; 2021; 296():100667. PubMed ID: 33864813
[TBL] [Abstract][Full Text] [Related]
12. Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.
Bettaieb A; Koike S; Chahed S; Zhao Y; Bachaalany S; Hashoush N; Graham J; Fatima H; Havel PJ; Gruzdev A; Zeldin DC; Hammock BD; Haj FG
FEBS J; 2017 Jul; 284(13):1970-1986. PubMed ID: 28485854
[TBL] [Abstract][Full Text] [Related]
13. Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy.
Maayah ZH; McGinn E; Al Batran R; Gopal K; Ussher JR; El-Kadi AOS
J Cardiovasc Pharmacol; 2019 Sep; 74(3):235-245. PubMed ID: 31306370
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase deficiency attenuates lipotoxic cardiomyopathy via upregulation of AMPK-mTORC mediated autophagy.
Wang L; Zhao D; Tang L; Li H; Liu Z; Gao J; Edin ML; Zhang H; Zhang K; Chen J; Zhu X; Wang D; Zeldin DC; Hammock BD; Wang J; Huang H
J Mol Cell Cardiol; 2021 May; 154():80-91. PubMed ID: 33378686
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.
Wepler M; Beloiartsev A; Buswell MD; Panigrahy D; Malhotra R; Buys ES; Radermacher P; Ichinose F; Bloch DB; Zapol WM
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1213-L1221. PubMed ID: 27815261
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
[TBL] [Abstract][Full Text] [Related]
17. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.
Chen G; Xu R; Wang Y; Wang P; Zhao G; Xu X; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E563-75. PubMed ID: 22739108
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
19. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke.
Zuloaga KL; Krasnow SM; Zhu X; Zhang W; Jouihan SA; Shangraw RE; Alkayed NJ; Marks DL
PLoS One; 2014; 9(5):e97529. PubMed ID: 24824753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
